Insight Molecular Diagnostics (IMDX) EPS (2015 - 2026)
Insight Molecular Diagnostics (IMDX) EPS from Dec 31, 2015 to Mar 31, 2026. The TTM Insight Molecular Diagnostics (IMDX) EPS is -$1.65. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Insight Molecular Diagnostics (IMDX) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -52.80% |
| 3 Years TTM | -45.21% |
| 5 Years TTM | -25.98% |
| 10 Years TTM | -10.65% |
| All Time TTM | -15.98% |
Annual EPS change of Insight Molecular Diagnostics (IMDX)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.13 | -92.41% |
| 2025 | -$1.75 | -49.62% |
| 2024 | -$3.48 | +3.36% |
| 2023 | -$3.36 | -72.64% |
| 2022 | -$12.29 | -11.59% |
| 2021 | -$13.90 | +60.49% |
| 2020 | -$8.66 | +10.11% |
| 2019 | -$7.87 | +1.54% |
| 2018 | -$7.75 | -38.97% |
| 2017 | -$12.69 | +53.52% |
| 2016 | -$8.27 | +196.49% |
| 2015 | -$2.79 | N/A |
Comparison Insight Molecular Diagnostics (IMDX) five years EPS CAGR with competitors
Insight Molecular Diagnostics (IMDX) five years EPS CAGR is -25.97%.
| Ticker | Name | five years EPS CAGR | Upside |
|---|---|---|---|
| NOTV | Inotiv, Inc. Common Stock | 62.28% | -339.79% |
| IQV | IQVIA Holdings Inc | 30.82% | -218.65% |
| MEDP | Medpace Holdings Inc | 29.42% | -213.28% |
| WAT | Waters Corp | 15.00% | -157.75% |
| TMO | Thermo Fisher Scientific Inc | 14.94% | -157.51% |
| IDXX | Idexx Laboratories Inc | 11.68% | -144.95% |
| MTD | Mettler-Toledo International Inc | 10.58% | -140.72% |
| A | Agilent Technologies Inc | 10.55% | -140.63% |
| DGX | Quest Diagnostics Inc | 8.13% | -131.29% |
| QGEN | Qiagen NV | 3.15% | -112.15% |
| GH | Guardant Health Inc | 1.05% | -104.03% |